Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing earlier that it's depression disorder treatment tasimelteon had failed to meet its endpoint in Phase IIb/III trials.
Shares of Vanda Pharmaceutical (VNDA -11.8%) take a hit in early trading after announcing...
Recommended For You
More Trending News
About VNDA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VNDA | - | - |
| Vanda Pharmaceuticals Inc. | ||